This site is intended for health professionals only

Published on 22 June 2007

Share this story:

RELATED ARTICLES
Denosumab for menopausal and cancer-related bone loss
Patient knowledge of colorectal cancer therapy side-effects
Understanding compassionate-use programmes
ECCMID: Developments in invasive fungal disease
ECCO President’s preview of the Congress

US go-ahead for Exforge

teaser

↓Article continues below this sponsored advert↓
↑Advertisement↑

Novartis has received US approval for Exforge






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Long-term marine omega-3 fatty acid use leads to slight increased risk of depression in older adults
Launch of DVD for kidney disease
Diabetes hope for malaria drug
Sanofi and Regeneron announce approval of Praluent® for the treatment of hypercholesterolaemia in the EU
Combined arthritis treatment hailed
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x